356 related articles for article (PubMed ID: 31653568)
1. 53BP1 Enforces Distinct Pre- and Post-resection Blocks on Homologous Recombination.
Callen E; Zong D; Wu W; Wong N; Stanlie A; Ishikawa M; Pavani R; Dumitrache LC; Byrum AK; Mendez-Dorantes C; Martinez P; Canela A; Maman Y; Day A; Kruhlak MJ; Blasco MA; Stark JM; Mosammaparast N; McKinnon PJ; Nussenzweig A
Mol Cell; 2020 Jan; 77(1):26-38.e7. PubMed ID: 31653568
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.
Zong D; Adam S; Wang Y; Sasanuma H; Callén E; Murga M; Day A; Kruhlak MJ; Wong N; Munro M; Ray Chaudhuri A; Karim B; Xia B; Takeda S; Johnson N; Durocher D; Nussenzweig A
Mol Cell; 2019 Mar; 73(6):1267-1281.e7. PubMed ID: 30704900
[TBL] [Abstract][Full Text] [Related]
3. 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in.
Mirman Z; Lottersberger F; Takai H; Kibe T; Gong Y; Takai K; Bianchi A; Zimmermann M; Durocher D; de Lange T
Nature; 2018 Aug; 560(7716):112-116. PubMed ID: 30022158
[TBL] [Abstract][Full Text] [Related]
4. 53BP1-shieldin-dependent DSB processing in BRCA1-deficient cells requires CST-Polα-primase fill-in synthesis.
Mirman Z; Sasi NK; King A; Chapman JR; de Lange T
Nat Cell Biol; 2022 Jan; 24(1):51-61. PubMed ID: 35027730
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance.
Nacson J; Krais JJ; Bernhardy AJ; Clausen E; Feng W; Wang Y; Nicolas E; Cai KQ; Tricarico R; Hua X; DiMarcantonio D; Martinez E; Zong D; Handorf EA; Bellacosa A; Testa JR; Nussenzweig A; Gupta GP; Sykes SM; Johnson N
Cell Rep; 2018 Sep; 24(13):3513-3527.e7. PubMed ID: 30257212
[TBL] [Abstract][Full Text] [Related]
6. DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.
Gupta R; Somyajit K; Narita T; Maskey E; Stanlie A; Kremer M; Typas D; Lammers M; Mailand N; Nussenzweig A; Lukas J; Choudhary C
Cell; 2018 May; 173(4):972-988.e23. PubMed ID: 29656893
[TBL] [Abstract][Full Text] [Related]
7. The shieldin complex mediates 53BP1-dependent DNA repair.
Noordermeer SM; Adam S; Setiaputra D; Barazas M; Pettitt SJ; Ling AK; Olivieri M; Álvarez-Quilón A; Moatti N; Zimmermann M; Annunziato S; Krastev DB; Song F; Brandsma I; Frankum J; Brough R; Sherker A; Landry S; Szilard RK; Munro MM; McEwan A; Goullet de Rugy T; Lin ZY; Hart T; Moffat J; Gingras AC; Martin A; van Attikum H; Jonkers J; Lord CJ; Rottenberg S; Durocher D
Nature; 2018 Aug; 560(7716):117-121. PubMed ID: 30022168
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 Mutational Complementation Induces Synthetic Viability.
Nacson J; Di Marcantonio D; Wang Y; Bernhardy AJ; Clausen E; Hua X; Cai KQ; Martinez E; Feng W; Callén E; Wu W; Gupta GP; Testa JR; Nussenzweig A; Sykes SM; Johnson N
Mol Cell; 2020 Jun; 78(5):951-959.e6. PubMed ID: 32359443
[TBL] [Abstract][Full Text] [Related]
9. CCAR2 functions downstream of the Shieldin complex to promote double-strand break end-joining.
Iyer DR; Harada N; Clairmont C; Jiang L; Martignetti D; Nguyen H; He YJ; Chowdhury D; D'Andrea AD
Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2214935119. PubMed ID: 36442094
[TBL] [Abstract][Full Text] [Related]
10. RNF8 regulates assembly of RAD51 at DNA double-strand breaks in the absence of BRCA1 and 53BP1.
Nakada S; Yonamine RM; Matsuo K
Cancer Res; 2012 Oct; 72(19):4974-83. PubMed ID: 22865450
[TBL] [Abstract][Full Text] [Related]
11. Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells.
Dev H; Chiang TW; Lescale C; de Krijger I; Martin AG; Pilger D; Coates J; Sczaniecka-Clift M; Wei W; Ostermaier M; Herzog M; Lam J; Shea A; Demir M; Wu Q; Yang F; Fu B; Lai Z; Balmus G; Belotserkovskaya R; Serra V; O'Connor MJ; Bruna A; Beli P; Pellegrini L; Caldas C; Deriano L; Jacobs JJL; Galanty Y; Jackson SP
Nat Cell Biol; 2018 Aug; 20(8):954-965. PubMed ID: 30022119
[TBL] [Abstract][Full Text] [Related]
12. RIF1 acts in DNA repair through phosphopeptide recognition of 53BP1.
Setiaputra D; Escribano-Díaz C; Reinert JK; Sadana P; Zong D; Callen E; Sifri C; Seebacher J; Nussenzweig A; Thomä NH; Durocher D
Mol Cell; 2022 Apr; 82(7):1359-1371.e9. PubMed ID: 35216668
[TBL] [Abstract][Full Text] [Related]
13. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
Cong K; Peng M; Kousholt AN; Lee WTC; Lee S; Nayak S; Krais J; VanderVere-Carozza PS; Pawelczak KS; Calvo J; Panzarino NJ; Turchi JJ; Johnson N; Jonkers J; Rothenberg E; Cantor SB
Mol Cell; 2021 Aug; 81(15):3128-3144.e7. PubMed ID: 34216544
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 Directs the Repair Pathway to Homologous Recombination by Promoting 53BP1 Dephosphorylation.
Isono M; Niimi A; Oike T; Hagiwara Y; Sato H; Sekine R; Yoshida Y; Isobe SY; Obuse C; Nishi R; Petricci E; Nakada S; Nakano T; Shibata A
Cell Rep; 2017 Jan; 18(2):520-532. PubMed ID: 28076794
[TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase 1 acts as a RIF1 effector to suppress DSB resection prior to Shieldin action.
Isobe SY; Hiraga SI; Nagao K; Sasanuma H; Donaldson AD; Obuse C
Cell Rep; 2021 Jul; 36(2):109383. PubMed ID: 34260925
[TBL] [Abstract][Full Text] [Related]
16. Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps.
Paes Dias M; Tripathi V; van der Heijden I; Cong K; Manolika EM; Bhin J; Gogola E; Galanos P; Annunziato S; Lieftink C; Andújar-Sánchez M; Chakrabarty S; Smith GCM; van de Ven M; Beijersbergen RL; Bartkova J; Rottenberg S; Cantor S; Bartek J; Ray Chaudhuri A; Jonkers J
Mol Cell; 2021 Nov; 81(22):4692-4708.e9. PubMed ID: 34555355
[TBL] [Abstract][Full Text] [Related]
17. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress.
Chroma K; Mistrik M; Moudry P; Gursky J; Liptay M; Strauss R; Skrott Z; Vrtel R; Bartkova J; Kramara J; Bartek J
Oncogene; 2017 Apr; 36(17):2405-2422. PubMed ID: 27841863
[TBL] [Abstract][Full Text] [Related]
18. RING finger nuclear factor RNF168 is important for defects in homologous recombination caused by loss of the breast cancer susceptibility factor BRCA1.
Muñoz MC; Laulier C; Gunn A; Cheng A; Robbiani DF; Nussenzweig A; Stark JM
J Biol Chem; 2012 Nov; 287(48):40618-28. PubMed ID: 23055523
[TBL] [Abstract][Full Text] [Related]
19. The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity.
Becker JR; Cuella-Martin R; Barazas M; Liu R; Oliveira C; Oliver AW; Bilham K; Holt AB; Blackford AN; Heierhorst J; Jonkers J; Rottenberg S; Chapman JR
Nat Commun; 2018 Dec; 9(1):5406. PubMed ID: 30559443
[TBL] [Abstract][Full Text] [Related]
20. Nanoscopic analysis of 53BP1, BRCA1 and Rad51 reveals new insights in temporal progression of DNA-repair and pathway choice.
Schwarz B; Friedl AA; Girst S; Dollinger G; Reindl J
Mutat Res; 2019 Nov; 816-818():111675. PubMed ID: 31302572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]